Evidence map›Paper›PMID 34371884›Full record

Trial reportNutrients2021

Reversal of Insulin Resistance in Overweight and Obese Subjects by

Naila Rabbani, Mingzhan Xue, Martin O Weickert, Paul J Thornalley

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Modulation of Aging Diseases via RAGE Targets: A Dietary Intervention Review.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  16. Review
  17. Biomolecules & therapeutics · 2025
    Article
  18. Article
  19. Glyoxalase 1 Inducer,Antioxidants (Basel, Switzerland) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Naila RabbaniDepartment of Basic Medical Science, College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.
Mingzhan XueDiabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha P.O. Box 34110, Qatar.
Martin O WeickertEndocrinology & Metabolism, Warwickshire Institute for the Study of Diabetes, University Hospitals of Coventry & Warwickshire NHS Trust, Coventry CV2 2DX, UK.ORCID 0000-0002-4070-8164
Paul J ThornalleyDiabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha P.O. Box 34110, Qatar.
Hamad bin Khalifa University · QAQatar University · QAUniversity Hospitals Coventry and Warwickshire NHS Trust · GB

Funding

Innovate UK Project no 101129
6 · The paper itself

Abstract

The dietary supplement,

Indexed as

Insulin ResistanceAdultBlood PressureBody Mass IndexCarrier ProteinsCorrelation of DataCross-Over StudiesDietary SupplementsDouble-Blind MethodDrug Therapy, CombinationDyslipidemiasFemaleGlucose Metabolism DisordersGlycosylationHesperidinHumansCarrier ProteinshesperetinHesperidinInflammation MediatorsPyruvaldehydeResveratrolTumor Necrosis Factor-alphaTXNIP protein, humanglyoxalaseinsulin resistancelow-grade inflammationmethylglyoxalobesitypolyphenol

Identifiers

PMID34371884
PMCPMC8308792
OpenAlexW3178181224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.